174 related articles for article (PubMed ID: 8822924)
21. Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other.
Litvinov RI; Yakovlev S; Tsurupa G; Gorkun OV; Medved L; Weisel JW
Biochemistry; 2007 Aug; 46(31):9133-42. PubMed ID: 17630702
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the binding of factor Xa to fibrinogen/fibrin derivatives and localization of the factor Xa binding site on fibrinogen.
Iino M; Takeya H; Takemitsu T; Nakagaki T; Gabazza EC; Suzuki K
Eur J Biochem; 1995 Aug; 232(1):90-7. PubMed ID: 7556176
[TBL] [Abstract][Full Text] [Related]
23. Cloning of the complete coding sequence of rat fibrinogen B beta chain cDNA: interspecies conservation of fibrin beta 15-42 primary structure.
Courtney MA; Bunce LA; Neroni LA; Simpson-Haidaris PJ
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):487-96. PubMed ID: 7841303
[TBL] [Abstract][Full Text] [Related]
24. Identification and characterization of the thrombin binding sites on fibrin.
Meh DA; Siebenlist KR; Mosesson MW
J Biol Chem; 1996 Sep; 271(38):23121-5. PubMed ID: 8798504
[TBL] [Abstract][Full Text] [Related]
25. Zn2+ mediates high affinity binding of heparin to the αC domain of fibrinogen.
Fredenburgh JC; Leslie BA; Stafford AR; Lim T; Chan HH; Weitz JI
J Biol Chem; 2013 Oct; 288(41):29394-402. PubMed ID: 23990470
[TBL] [Abstract][Full Text] [Related]
26. Fibrinogen substrate recognition by staphylocoagulase.(pro)thrombin complexes.
Panizzi P; Friedrich R; Fuentes-Prior P; Richter K; Bock PE; Bode W
J Biol Chem; 2006 Jan; 281(2):1179-87. PubMed ID: 16230339
[TBL] [Abstract][Full Text] [Related]
27. Fibrinogen and fibrin structure and functions.
Mosesson MW
J Thromb Haemost; 2005 Aug; 3(8):1894-904. PubMed ID: 16102057
[TBL] [Abstract][Full Text] [Related]
28. The core protein of the matrix-associated heparan sulfate proteoglycan binds to fibronectin.
Heremans A; De Cock B; Cassiman JJ; Van den Berghe H; David G
J Biol Chem; 1990 May; 265(15):8716-24. PubMed ID: 2140362
[TBL] [Abstract][Full Text] [Related]
29. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
[TBL] [Abstract][Full Text] [Related]
30. Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation.
Park K; Verchere CB
J Biol Chem; 2001 May; 276(20):16611-6. PubMed ID: 11145957
[TBL] [Abstract][Full Text] [Related]
31. Bivalent binding to gammaA/gamma'-fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex.
Fredenburgh JC; Stafford AR; Leslie BA; Weitz JI
J Biol Chem; 2008 Feb; 283(5):2470-7. PubMed ID: 18055456
[TBL] [Abstract][Full Text] [Related]
32. Measurement of the affinities of heparins, naturally occurring glycosaminoglycans, and other sulfated polymers for antithrombin III and thrombin.
Dawes J
Anal Biochem; 1988 Oct; 174(1):177-86. PubMed ID: 3218731
[TBL] [Abstract][Full Text] [Related]
33. Expression of primary polymerization sites in the D domain of human fibrinogen depends on intact conformation.
Cierniewski CS; Kloczewiak M; Budzynski AZ
J Biol Chem; 1986 Jul; 261(20):9116-21. PubMed ID: 3722190
[TBL] [Abstract][Full Text] [Related]
34. Thrombin interaction with fibrin polymerization sites.
Hsieh K
Thromb Res; 1997 May; 86(4):301-16. PubMed ID: 9187018
[TBL] [Abstract][Full Text] [Related]
35. Molecular mapping of the heparin-binding exosite of thrombin.
Sheehan JP; Sadler JE
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5518-22. PubMed ID: 8202520
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation.
Sahni A; Francis CW
Blood; 2000 Dec; 96(12):3772-8. PubMed ID: 11090059
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of B beta 68 Ala----Thr.
Koopman J; Haverkate F; Lord ST; Grimbergen J; Mannucci PM
J Clin Invest; 1992 Jul; 90(1):238-44. PubMed ID: 1634610
[TBL] [Abstract][Full Text] [Related]
38. Binding of urinary protein C inhibitor to fibrin(ogen) and its binding mechanism.
Hayashi S; Yamada K
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):153-8. PubMed ID: 8384496
[TBL] [Abstract][Full Text] [Related]
39. Late-fibrin(ogen) fragment E modulates human alpha-thrombin specificity.
Bouton MC; Jandrot-Perrus M; Bezeaud A; Guillin MC
Eur J Biochem; 1993 Jul; 215(1):143-9. PubMed ID: 8393788
[TBL] [Abstract][Full Text] [Related]
40. Evidence that catalytically-inactivated thrombin forms non-covalently linked dimers that bridge between fibrin/fibrinogen fibers and enhance fibrin polymerization.
Mosesson MW; Hernandez I; Siebenlist KR
Biophys Chem; 2004 Jul; 110(1-2):93-100. PubMed ID: 15223147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
